Al-Ghadeer HA,Al-Barqi M,Al-Maqhawi A,Alsultan AS,Alghafli JA,Al-Omaish MA .2021 .Prevalence of dyslipidemia in patients with type 2 diabetes mellitus: A cross-sectional study. Cureus, 13 : 123-42.
Bruemmer D,Nissen SE .2020 .Prevention, and management of cardiovascular disease in patients with diabetes: current challenges and opportunities. Cardiovasc Endocrinol Metabol, 9 : 81-90.
Li D,Wu T,Wang T,Wei H,Wang A,Tang H .2020 .Effects of sodium glucose cotransporter 2 inhibitors on risk of dyslipidemia among patients with type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials. Pharm Epidemiol Drug Saf, 29 : 582-90.
Jafarnejad S,Mahboobi S,McFarland LV,Taghizadeh M .2019 .Meta-analysis: effects of zinc supplementation alone or with multi-nutrients on glucose control and lipid levels in patients with type 2 diabetes. Prev Nutr Food Sci, 24 : 8-21.
Dybiec J,Baran W,Dąbek B,Fularski P,Młynarska E,Radzioch E .2023 .Advances in the treatment of dyslipidemia. Int J Mol Sci, 24 : 132-88.
Geng Q,Hou F,Zhang Y,Wang Z,Zhao M. .2022 .Effects of different doses of canagliflozin on blood pressure and lipids in patients with type 2 diabetes: a meta-analysis. J Hyper, 40 : 996-1001.
Kutoh E,Kuto AN,Wada A,Kurihara R,Kojima R .2022 .Regulations of free fatty acids and diabetic parameters in drug naïve subjects with type 2 diabetes treated with canagliflozin monotherapy. Drug Res, 72 : 86-93.
Nazarizadeh A,Asri-Rezaie S A .2016 .Comparative study of antidiabetic activity and oxidative stress induced by zinc oxide nanoparticles and zinc sulfate in diabetic rats. AAPS Pharm Sci Tech, 17 : 834-43.
Maulidia M,Wibowo JW,Sumarawati T,Decrease LDL .2022 .and IL-6 in Hyper cholesterol Male Wistar Rats. Indonesian J Med, 7 : 471-8.
Marie M,Arafa N .2015 .Sara Abdullah Mubarak A. Effect of canagliflozin or metformin on metabolic disorders in obese diabetic rats. Afr J Pharm Pharmacol, 9 : 1071-9.
Huang H,Liao D,Dong Y,Pu R .2020 .Effect of quercetin supplementation on plasma lipid profiles, blood pressure, and glucose levels: a systematic review and meta-analysis. Nutr Rev, 78 : 615-26.
Nelson AJ,Rochelau SK,Nicholls SJ .2018 .Managing dyslipidemia in type 2 diabetes. Endocrinol Metab Clin North Am, 47 : 153-73.
Seyedmahalleh MH,Montazer M,Ebrahimpour-Koujan S,Azadbakht L .2023 .The effect of zinc supplementation on lipid profiles in type-2 diabetes mellitus patients: a systematic review and dose-response meta-analysis of randomized clinical trials. Advan Nutr, 34 : 321-33.
Shamardl H,Sadek S,Ahmed A .2023 .Assessment of SGLT2 Inhibitor, Canagliflozin Effects on Metabolic SyndromeInduced Cardiovascular Disorders in Rats. Fay Univ Med J, 12 : 84-94.
Attia H,Al-Rasheed N,Faddah L .2015 .The combination of zinc and glibenclamide limits cardiovascular complications in diabetic rats via multiple mechanisms. Pak J Pharm Sci, 28 : 489-98.